ARTICLE · 26 DECEMBER 2024

Cannabis Law And Legislation In China

CMS

Contributor

CMS

CMS

CMS Wistrand is a Future Facing firm. With a deep local market understanding combined with a global...

View firm profile

Explore more from CMS

The PRC Drugs Prohibition Law classifies "marijuana"—products from the plant Cannabis sativa that contain substantial amounts of tetrahydrocannabinol (THC)—as drugs and prohibits its use in any form

ChinaCannabis & Hemp

Medical Use

The PRC Drugs Prohibition Law classifies "marijuana"—products from the plant Cannabis sativa that contain substantial amounts of tetrahydrocannabinol (THC)—as drugs and prohibits its use in any form. Additionally, the cultivation of drug-producing plants, including without limitation to cannabis, is generally illegal under PRC law. According to the PRC Criminal Law, such plants cultivated will be subject to compulsory eradication, and the offender shall be sentenced to fixed-term imprisonment, detention or control, and shall be fined.

However, certain kinds of cannabis that do not contain substantial amounts of THC can be used as narcotic drugs or psychotropic drugs. The following are listed in the latest Catalogue of Narcotic Drugs and the Catalogue of Psychotropic Drugs (2013 version): cannabis and cannabis resin, extracts and tinctures of cannabis , parahexyl, tetrahydrocannabinol and dronabinol.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

CMS

Supreme People's Court Issued Interpretation On Punitive Damages For Food And Drug Disputes

The Supreme People's Court ("SPC") of the People's Republic of China ("PRC") has recently promulgated the Interpretation on Several Issues Concerning the Application of Law to the Trial of Cases of Disputes over Punitive Damages in Food and Drugs ("Interpretation"), taking effect from August 22, 2024.

ChinaFood, Drugs, Healthcare, Life Sciences

Further Strengthening The Supervision Of Entrusted Manufacturing Of Medical Devices: Key Takeaways From NMPA's New Notice

On 3 April 2024, the National Medical Products Administration ("NMPA") released the Notice on Further Strengthening the Supervision and Management of Entrusted Manufacturing...

ChinaFood, Drugs, Healthcare, Life Sciences

Circular On The Work Relating To The Implementation Of GB 9706.1-2020 And Supporting Concurrent Standards And Special Standards

The National Medical Products Administration ("NMPA") issued the Circular on the Work Relating to the Implementation of GB 9706.1-2020 and Supporting Concurrent Standards and Special Standards

ChinaFood, Drugs, Healthcare, Life Sciences

The End Of Local Financial Incentives In China?

For decades, it has been common practice that local governments attract investors by offering them various financial incentives mostly in the form of subsidies.

ChinaGovernment, Public Sector

Measures For Supervision And Administration Of The Quality Of Drug Supply And Use

To implement the Drug Administration Law of the PRC, a draft version of the Measures for Supervision and Administration of Drug Supply was publicized in September 2019 for public opinion

ChinaFood, Drugs, Healthcare, Life Sciences

CIETAC Publishes Arbitration Rules For Investor-State Disputes

On 19 September 2017, the China International Economic and Trade Arbitration Commission ("CIETAC") published the Arbitration Rules of the China International Economic and Trade Arbitration Commission...

ChinaInternational Law

A New Adventure For Wholly Foreign Invested Hospital

Wholly foreign-invested hospitals have always been a sector under relatively strict regulation in the PRC, except for limited cases as pilots.

ChinaFood, Drugs, Healthcare, Life Sciences

2024 – Topics That May Concern You

On 29 December 2023, the Standing Committee of the National People's Congress issued a major update to the current PRC Company Law. The revised PRC Company Law will enter into effect on 1 July 2024.